Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study
Launched by UNIVERSITY OF COLORADO, DENVER · Oct 30, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Tunawiri Study is a clinical trial in Kenya that aims to help pregnant women living with HIV who are also dealing with common mental health issues. The study focuses on creating a supportive care model that combines mental health support with regular HIV and pregnancy care. By working closely with healthcare providers and the community, the researchers hope to improve the well-being of these women and their families during and after pregnancy.
To participate in this study, women need to be pregnant, living with HIV, and attending an antenatal clinic in southwestern Kenya. They should also be experiencing some mental health challenges but not have severe mental health issues that could lead to immediate harm. Participants will receive tailored support to help manage both their mental health and HIV care throughout their pregnancy. This study not only aims to enhance individual health outcomes but also looks into how this approach can be expanded and sustained for others in similar situations.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant woman living with HIV attending an antenatal clinic in southwestern Kenya
- • screening positive for probable common mental disorders
- • living in catchment area of study facility.
- • on/initiating ART
- • \>15 years of age
- Exclusion Criteria:
- • imminent plans of suicide
- • severe impairment due to severe mental, neurological or substance use disorders.
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nairobi, , Kenya
Patients applied
Trial Officials
Lisa Abuogi, MD, MSc
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported